Id proteins & neovascularization of spontaneous tumors
Id蛋白
基本信息
- 批准号:6764661
- 负责人:
- 金额:$ 47.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding proteinRNA interferenceangiogenesisbone marrowcell cycledisease /disorder modelgenetic regulationgenetically modified animalsinhibitor /antagonistlaboratory mousemicroarray technologyneoplasm /cancer blood supplyneoplastic growthprotein structure functionstem cellstranscription factortransfection /expression vectorvascular endothelial growth factors
项目摘要
DESCRIPTION (provided by applicant): The Id proteins Id1 and Id3 have been shown to be essential for neovascularization of subcutaneous tumors in mice. These proteins, which inhibit the activity of basic helix loop helix transcription factors, have been shown by gene targeting experiments to be essential for the expansion of circulating endothelial cell precursors (CEPs) in the bone marrow (BM) and their mobilization into the periphery in response to elevated plasma levels of VEGF. The Id knockout mice have therefore been useful in modeling the effects of severe anti-angiogenic stress in adult animals. The current proposal is designed to expand these observations in several important ways. First, we will determine if BM derived CEPs vascularize spontaneous murine tumors since such models are much more physiologically relevant to human disease. The functional significance of such a contribution will also be tested by transplanting Id knockout animals with marked wild type BM. In addition, we will determine if Id loss in BM derived lin- stem cells is sufficient to confer the Id knockout phenotype in order to formally demonstrate the requirement for Id in BM derived angioblasts. Finally, we will identify Id target genes, which are misregulated in the BM of Id knockout animals in response to VEGF. These studies will further our understanding of the role of Id proteins in postnatal angiogenesis and more generally the molecular mechanisms of neoangiogenesis in spontaneous tumors.
描述(由申请人提供):Id蛋白Id1和Id3已被证明对小鼠皮下肿瘤的新生血管至关重要。这些蛋白抑制基本螺旋环螺旋转录因子的活性,基因靶向实验表明,这些蛋白对于骨髓(BM)中循环内皮细胞前体(cep)的扩张以及它们在血浆VEGF水平升高时向外周的动员至关重要。因此,Id敲除小鼠在模拟成年动物严重抗血管生成应激的影响方面是有用的。目前的建议旨在从几个重要方面扩展这些观察结果。首先,我们将确定BM衍生的cep是否会使自发性小鼠肿瘤血管化,因为这种模型在生理上与人类疾病更相关。这种贡献的功能意义也将通过移植带有标记野生型BM的Id敲除动物来测试。此外,为了正式证明BM来源的成血管细胞对Id的需求,我们将确定BM来源的lin- stem细胞中的Id缺失是否足以赋予Id敲除表型。最后,我们将确定Id靶基因,这些基因在Id敲除动物的BM中响应VEGF而被错误调控。这些研究将进一步加深我们对Id蛋白在出生后血管生成中的作用的理解,并更广泛地了解自发性肿瘤中新生血管生成的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT I BENEZRA其他文献
ROBERT I BENEZRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT I BENEZRA', 18)}}的其他基金
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
模拟 BRAF 融合驱动的小鼠小儿脑肿瘤
- 批准号:
10413181 - 财政年份:2019
- 资助金额:
$ 47.5万 - 项目类别:
Modeling BRAF-fusion driven pediatric brain tumors in the mouse
模拟 BRAF 融合驱动的小鼠小儿脑肿瘤
- 批准号:
10672917 - 财政年份:2019
- 资助金额:
$ 47.5万 - 项目类别:
The Role of Id Proteins in Breast Tumorigenesis
Id 蛋白在乳腺肿瘤发生中的作用
- 批准号:
7438488 - 财政年份:2008
- 资助金额:
$ 47.5万 - 项目类别:
The role of endothelial progenitor cells in tumor growth and metastasis
内皮祖细胞在肿瘤生长和转移中的作用
- 批准号:
8113675 - 财政年份:2004
- 资助金额:
$ 47.5万 - 项目类别:
The role of endothelial progenitor cells in tumor growth and metastasis
内皮祖细胞在肿瘤生长和转移中的作用
- 批准号:
8635982 - 财政年份:2004
- 资助金额:
$ 47.5万 - 项目类别:
The role of endothelial progenitor cells in tumor growth and metastasis
内皮祖细胞在肿瘤生长和转移中的作用
- 批准号:
8447575 - 财政年份:2004
- 资助金额:
$ 47.5万 - 项目类别:
The role of endothelial progenitor cells in tumor growth and metastasis
内皮祖细胞在肿瘤生长和转移中的作用
- 批准号:
8245011 - 财政年份:2004
- 资助金额:
$ 47.5万 - 项目类别:
相似海外基金
Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
- 批准号:
23K10830 - 财政年份:2023
- 资助金额:
$ 47.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10539405 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10688080 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
- 批准号:
DP220101361 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10677770 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
- 批准号:
RGPIN-2019-04411 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
- 批准号:
2143019 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
- 批准号:
486535 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10330828 - 财政年份:2022
- 资助金额:
$ 47.5万 - 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
- 批准号:
2046602 - 财政年份:2021
- 资助金额:
$ 47.5万 - 项目类别:
Continuing Grant














{{item.name}}会员




